Subscribe To

Price Alert Latest News Economic Calendar News

SNCE / Science 37 to Report Fourth Quarter and Full Year 2021 Financial Results on March 22, 2022

RESEARCH TRIANGLE PARK, N.C., March 08, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report fourth quarter and full year 2021 financial results before the market opens on Tuesday, March 22, 2022. Company management will host a corresponding conference call at 5:00 a.m. Pacific Time / 8:00 a.m. Eastern Time. Read More

Demo Live Account See Partner Details

Content Topics

Science

Report

Fourth

Quarter

Full

Year

2021

Financial

Results

Stock

SNCE

Posted: Mar 8 2022, 07:55

Author Name: GlobeNewsWire

SNCE News

By GlobeNewsWire
October 24, 2023

Science 37 to Report Third Quarter 2023 Financial Results on November 7, 2023

RESEARCH TRIANGLE PARK, N.C., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today annou

By Seeking Alpha
August 12, 2023

Science 37 Holdings, Inc. (SNCE) Q2 2023 Earnings Call Transcript

Science 37 Holdings, Inc. (NASDAQ:SNCE ) Q2 2023 Results Conference Call August 8, 2023 8:30 AM ET Company Participants Steven Halper - LifeSci Adviso

By InvestorPlace
March 13, 2023

Why Is Science 37 (SNCE) Stock Up 9% Today?

Science 37 (NASDAQ: SNCE ) stock is rising higher on Monday following news of inducement equity awards for its Metasite employees. According to a pres

By GlobeNewsWire
May 25, 2022

Science 37® to Present at the William Blair 42nd Annual Growth Stock Conference

RESEARCH TRIANGLE PARK, N.C., May 25, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™,

By GlobeNewsWire
April 25, 2022

Science 37 to Report First Quarter 2022 Financial Results on May 9, 2022

RESEARCH TRIANGLE PARK, N.C., April 25, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System�

By Seeking Alpha
March 22, 2022

Science 37 Holdings, Inc. (SNCE) CEO David Coman on Q4 2021 Results - Earnings Call Transcript

By GlobeNewsWire
March 8, 2022

Science 37 to Report Fourth Quarter and Full Year 2021 Financial Results on March 22, 2022

RESEARCH TRIANGLE PARK, N.C., March 08, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System�

By GlobeNewsWire
February 23, 2022

Science 37® to Present at the Cowen 42nd Annual Health Care Conference

RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.